Scientific Library
- Acute Coronary Syndrom
- ASCVD Prevention
- Bifurcation Stenting
- Cardio-Oncology
- Congestive Heart Failure
- DAPT Duration
- Drug Coated Balloon
- Fractional Flow Reserve
- IVUS Guidance
- Optical Coherence Tomography
- Pulmonary Hypertension
- Rotational Atherectomy
- Shear Stress
- Stenting Left Main
- Transcatheter Aortic Valve Replacement
- Percutaneous LAA Occlusion
- Mitral/Tricuspid Valvular Disease
- Other Relevant Articles
-
Advances in Clinical Cardiology 2020: A Summary of Key Clinical TrialsA Kearney, K Linden, IBA Menown et al. -
Position paper of the EACVI and EANM on artificial intelligence applications in multimodality cardiovascular imaging using SPECT/CT, PET/CT, and cardiac CTRHJA Slart, MC Williams, LE Juarez-Orozco et al.
-
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice GuidelinesStone NJ, Robinson JG, American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
-
Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or with Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights from the AUGUSTUS TrialS Windecker , RD Lopes, AUGUSTUS Investigators et al.
-
De-escalation of antianginal medications after successful chronic total occlusion percutaneous coronary intervention: Frequency and relationship with health statusQintar M, Hirai T, Salisbury AC et al.
-
2017 ACC/AHA Blood Pressure Treatment Guideline Recommendations and Cardiovascular RiskLD Colantonio, JN Booth III, AP Bress et al.
-
Improving the Design of Future PCI Trials for Stable Coronary Artery Disease: JACC State-of-the-Art ReviewG Marquis-Gravel, DJ Moliterno, SG Goodman et al.
-
Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trialStone GW, Généreux P, Harrington RA et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
